Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
A Review of Preclinical Experiments Toward Targeting M2 Macrophages in Prostate Cancer Publisher Pubmed



Seif F1, 2 ; Sharifi L3 ; Khoshmirsafa M1, 2 ; Mojibi Y4 ; Mohsenzadegan M4
Authors

Source: Current Drug Targets Published:2019


Abstract

Prostate cancer is malignant cancer leading to high mortality in the male population. The existence of suppressive cells referred to as tumor-associated macrophages (TAM) is a major obstacle in prostate cancer immunotherapy. TAMs contribute to the immunosuppressive microenvironment that promotes tumor growth and metastasis. In fact, they are main regulators of the complicated interactions between tumor and surrounding microenvironment. M2 macrophages, as a type of TAMs, are involved in the growth and progression of prostate cancer. Recently, they have gained remarkable importance as therapeutic candidates for solid tumors. In this review, we will discuss the roles of M2 macrophages and worth of their potential targeting in prostate cancer treatment. In the following, we will introduce important factors resulting in M2 macrophage promotion and also experimental therapeutic agents that may cause the inhibition of prostate cancer tumor growth. © 2019 Bentham Science Publishers.
Other Related Docs
12. Macrophage’S Role in Solid Tumors: Two Edges of a Sword, Cancer Cell International (2023)
16. Roles of Myeloid-Derived Suppressor Cells in Cancer Metastasis: Immunosuppression and Beyond, Archivum Immunologiae et Therapiae Experimentalis (2019)
20. Reprogramming Tumor-Associated Macrophages Using Exosomes From M1 Macrophages, Biochemical and Biophysical Research Communications (2024)